Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06207188 · ClinicalTrials.gov registry record

Identification and Differentiation of Thyroid Nodules by Acoustic Imaging and Viscoelastic Parameters

A clinical trial of Thyroid Gland Carcinoma, sponsored by Mayo Clinic.

Recruiting
Registry status
650
Enrollment target
3
Study locations

NCT06207188: Recruiting study of Thyroid Gland Carcinoma, sponsored by Mayo Clinic.

NCT06207188 is a study of Thyroid Gland Carcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 650 participants, above the 581-participant average among 3 other Thyroid Gland Carcinoma trials with a reported enrollment target (12% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06207188, a study of Thyroid Gland Carcinoma, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
650 participants
Enrollment target
3
Study locations

Study Summary

This study is being done to identify and differentiate thyroid nodules by acoustic imaging and viscoelastic parameters.

Primary Outcome

Successful nodule localization will be assessed by the review of the VA image relative to the nodule location information from the reference ultrasound (US) image (agree/disagree on location will be determined for each nodule).

Conditions Studied

Interventions

  • OTHER Non-Interventional Study

Study Locations (3)

Arizona

  • Mayo Clinic in Arizona - Scottsdale

Florida

  • Mayo Clinic in Florida - Jacksonville

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 650 participants
Start Date 2009-05-17
Est. Completion 2026-12-31
Mayo Clinic

2,844 total trials

What NCT06207188 shows while recruiting

NCT06207188 is an observational study that tracks outcomes without assigning an intervention. The registered 650 participants enrollment target is mid-sized for trials with a published cap, above the 581-participant average among 3 other Thyroid Gland Carcinoma trials with a reported enrollment target (12% higher).

The record links to 1 condition, with Thyroid Gland Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.

NCT06207188 reports a single indexed study location in Arizona, Florida, Minnesota.

Frequently Asked Questions

What is clinical trial NCT06207188 about?

NCT06207188 is a clinical study titled "Identification and Differentiation of Thyroid Nodules by Acoustic Imaging and Viscoelastic Parameters". This study is being done to identify and differentiate thyroid nodules by acoustic imaging and viscoelastic parameters.

What is the current status of trial NCT06207188?

This trial is currently recruiting. The enrollment target is 650 participants. The study started on 2009-05-17. Estimated completion is 2026-12-31.

What conditions does trial NCT06207188 study?

This clinical trial studies the following conditions: Thyroid Gland Carcinoma.

What interventions are being tested in trial NCT06207188?

The interventions under investigation include: Non-Interventional Study (OTHER).

Who is sponsoring clinical trial NCT06207188?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06207188 being conducted?

This trial has 3 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thyroid Gland Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02934477 · 650 participants

    Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis

  • NCT04579120 · 650 participants

    Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)

  • NCT04875702 · 650 participants · Phase 4

    Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout

  • NCT05046600 · 650 participants

    Registry of Arthrex Hand and Wrist Products

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06207188, the US trial registry maintained by the National Library of Medicine. NCT06207188 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.